CN Stock MarketDetailed Quotes

Jiangsu Sinopep-Allsino Biopharmaceutical (688076)

Watchlist
  • 27.26
  • +0.36+1.34%
Market Closed Jun 12 15:00 CST
8.62BMarket Cap27.84P/E (TTM)

Jiangsu Sinopep-Allsino Biopharmaceutical (688076) Key Financial Indicators

688076 Earnings per Share (EPS)

According to the latest financial report of Jiangsu Sinopep-Allsino Biopharmaceutical, the latest earnings per share (TTM) for the company is 0.41. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

688076 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out Jiangsu Sinopep-Allsino Biopharmaceutical's latest financial report to see how much their book value per share (BVPS) is currently at 9.86.

Currency: CNY

Cumulative Quarterly

Loading...

688076 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Jiangsu Sinopep-Allsino Biopharmaceutical shows that the company's current ratio is 1.17, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

688076 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Jiangsu Sinopep-Allsino Biopharmaceutical, the quick ratio is 0.75, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

688076 Return on Equity (ROE)

Want to learn more about the financial health of Jiangsu Sinopep-Allsino Biopharmaceutical? The latest ROE figure is 4.24%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

688076 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Jiangsu Sinopep-Allsino Biopharmaceutical, the total asset return on investment (ROA) is 1.87%.

Currency: CNY

Cumulative Quarterly

Loading...

688076 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Jiangsu Sinopep-Allsino Biopharmaceutical's latest financial report to see how their gross margin is doing - currently at 61.97%.

Currency: CNY

Cumulative Quarterly

Loading...

688076 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Jiangsu Sinopep-Allsino Biopharmaceutical, the net profit margin is 22.95%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More